Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Second Sight (EYES)

Second Sight (EYES)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 144,812
  • Shares Outstanding, K 37,909
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,880 K
  • 60-Month Beta 3.38
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.13
Trade EYES with:

Options Overview

Details
  • Implied Volatility 115.33%
  • Historical Volatility 60.91%
  • IV Percentile 4%
  • IV Rank 12.46%
  • IV High 198.51% on 05/12/21
  • IV Low 103.49% on 07/20/21
  • Put/Call Vol Ratio 0.02
  • Today's Volume 762
  • Volume Avg (30-Day) 2,277
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 22,773
  • Open Int (30-Day) 24,176

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.45 +13.33%
on 07/19/21
5.28 -25.95%
on 07/22/21
-0.56 (-12.53%)
since 07/02/21
3-Month
3.45 +13.33%
on 07/19/21
7.64 -48.82%
on 06/16/21
-2.98 (-43.25%)
since 04/30/21
52-Week
0.69 +466.17%
on 09/08/20
20.00 -80.45%
on 03/09/21
+3.05 (+356.67%)
since 07/31/20

Most Recent Stories

More News
Second Sight Medical Products Announces Closing of Public Offering

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

EYES : 3.91 (+2.36%)
Second Sight Medical Products Announces Pricing of Public Offering

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

EYES : 3.91 (+2.36%)
Second Sight Medical Products Announces Proposed Public Offering of Common Stock

Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the "Company") a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

EYES : 3.91 (+2.36%)
Is Second Sight Medical Products a Winner in the Healthcare Sector?

Second Sight Medical Products (EYES) has found a market niche for itself in the healthcare space developing implantable visual prosthetics to treat sight-impaired people. With the U.S. FDA approval for...

EYES : 3.91 (+2.36%)
Global Bioelectric Medicine Market Share Estimated to Reach USD 36 Billion by 2026: Facts & Factors

Facts and Factors have published a new research report titled "Bioelectric Medicine Market By Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Deep Brain Stimulators,...

LIVN : 87.88 (+1.83%)
MDT : 131.26 (-0.04%)
EYES : 3.91 (+2.36%)
SONVF : 393.0000 (-0.02%)
STJ : 80.82 (+0.16%)
Second Sight Medical Products Announces Results of its 2021 Annual Meeting

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

EYES : 3.91 (+2.36%)
Company News for May 13, 2021

Companies in the news are: TM, LHDX, EYES, CVI

TM : 181.88 (+1.13%)
CVI : 13.53 (-0.95%)
EYES : 3.91 (+2.36%)
LHDX : 10.81 (+10.19%)
Second Sight Medical Products Announces Year Three NIH Funding of Its Orion Study

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision...

EYES : 3.91 (+2.36%)
Thinking about buying stock in Second Sight Medical, Plug Power, Array Technologies, Carnival Corp, or Intel Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EYES, PLUG, ARRY, CCL, and INTC.

ARRY : 12.96 (-4.28%)
INTC : 53.68 (-0.07%)
EYES : 3.91 (+2.36%)
PLUG : 26.62 (-2.42%)
CCL : 21.46 (-0.88%)
Second Sight Medical Products Announces Two-Year Results of its Orion Study

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of...

EYES : 3.91 (+2.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Second Sight Medical Products, Inc. is a medical device company. It develops, manufactures, and markets implantable prosthetic devices to restore some functional vision to blind patients. The Company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations,...

See More

Key Turning Points

3rd Resistance Point 4.24
2nd Resistance Point 4.13
1st Resistance Point 4.02
Last Price 3.91
1st Support Level 3.80
2nd Support Level 3.69
3rd Support Level 3.58

See More

52-Week High 20.00
Fibonacci 61.8% 12.62
Fibonacci 50% 10.35
Fibonacci 38.2% 8.07
Last Price 3.91
52-Week Low 0.69

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar